Known targets — ChEMBL curated mechanism
BRAFFLT1FLT3FLT4KDRKITPDGFRBRAF1RET
The experimentally established mechanism targets of Sorafenib. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDR known ✓ | P35968 | 6/20 | 0.98 |
| ▸ | RAF1 known ✓ | P04049 | 12/20 | 0.80 |
| ▸ | BRAF known ✓ | P15056 | 4/20 | 0.80 |
| ▸ | RET known ✓ | P07949 | 3/20 | 0.80 |
| ▸ | PDGFRB known ✓ | P09619 | 2/20 | 0.80 |
| ▸ | KIT known ✓ | P10721 | 2/20 | 0.80 |
| ▸ | FLT1 known ✓ | P17948 | 2/20 | 0.80 |
| ▸ | FLT4 known ✓ | P35916 | 2/20 | 0.80 |
| ▸ | FLT3 known ✓ | P36888 | 2/20 | 0.80 |
| ▸ | AURKB | Q96GD4 | 2/20 | 0.98 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.98 |
| ▸ | MC4R | P32245 | 1/20 | 0.98 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.98 |
| ▸ | RIPK2 | O43353 | 2/20 | 0.80 |
| ▸ | ABCB11 | O95342 | 2/20 | 0.80 |
| ▸ | ABL1 | P00519 | 2/20 | 0.80 |
| ▸ | HTR1A | P08908 | 2/20 | 0.80 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.80 |
| ▸ | FGFR1 | P11362 | 2/20 | 0.80 |
| ▸ | PDGFRA | P16234 | 2/20 | 0.80 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sorafenib SCHEMBL18496409 | 0.99 | KDR (1.00) | KDRAURKBNTSR1MC4RPAX8 | |
| Sorafenib SCHEMBL29919725 | 0.99 | KDR (1.00) | KDRAURKBNTSR1MC4RPAX8 | |
| Sorafenib SCHEMBL162935 | 0.99 | KDR (1.00) | KDRAURKBNTSR1MC4RPAX8 | |
| Sorafenib SCHEMBL15939735 | 0.99 | KDR (1.00) | KDRAURKBNTSR1MC4RPAX8 | |
| Sorafenib SCHEMBL3660939 | 0.98 | KDR (0.98) | KDRAURKBNTSR1MC4RPAX8 | |
| Sorafenib SCHEMBL3664023 | 0.96 | KDR (0.94) | KDRAURKBNTSR1MC4RPAX8 | |
| Sorafenib SCHEMBL16051185 | 0.96 | KDR (0.94) | KDRAURKBNTSR1MC4RPAX8 | |
| Cm-4307 SCHEMBL14673524 | 0.94 | KDR (0.90) | KDRAURKBNTSR1MC4RPAX8 | |
| Sorafenib SCHEMBL1702335 | 0.93 | KDR (0.85) | KDRAURKBNTSR1MC4RPAX8 | |
| Sorafenib SCHEMBL19322 | 0.92 | KDR (0.87) | KDRAURKBNTSR1MC4RPAX8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108368052-A | Sorafenib hemiparatoluenesulfonate monohydrate crystal and preparation method thereof | 正大天晴药业集团股份有限公司 | 2018-08-03 | — | — | CN | claimed |
| CN-107840823-A | For the method for the scalable for preparing Sorafenib Tosylate alcohol solvent compound and III type Sorafenib Tosylates | 意大利合成制造有限公司 | 2018-03-27 | — | — | CN | claimed |
| CN-117088809-A | Sorafenib-malonic acid eutectic crystal and preparation method thereof | 浙江工业大学 | 2023-11-21 | — | — | CN | disclosed |
| CN-109796400-B | Sorafenib tosylate crystal form and preparation method thereof | 四川科伦药物研究院有限公司 | 2022-07-29 | — | — | CN | disclosed |
| CN-106748996-B | Sorafenib tosylate crystal compound and preparation method thereof | 山东裕欣药业有限公司 | 2020-03-20 | — | — | CN | disclosed |
| CN-108368052-A | Sorafenib hemiparatoluenesulfonate monohydrate crystal and preparation method thereof | 正大天晴药业集团股份有限公司 | 2018-08-03 | — | — | CN | disclosed |
| CN-108368052-A | Sorafenib hemiparatoluenesulfonate monohydrate crystal and preparation method thereof | 正大天晴药业集团股份有限公司 | 2018-08-03 | — | — | CN | disclosed |
| CN-108368052-A | Sorafenib hemiparatoluenesulfonate monohydrate crystal and preparation method thereof | 正大天晴药业集团股份有限公司 | 2018-08-03 | — | — | CN | disclosed |
| CN-107840823-A | For the method for the scalable for preparing Sorafenib Tosylate alcohol solvent compound and III type Sorafenib Tosylates | 意大利合成制造有限公司 | 2018-03-27 | — | — | CN | disclosed |